VIRAMUNE, TABS/ 60/200MG BLI DE/AT D/A/HR

Boehringer Ing. Pharma GmbH & Co. KG

Revision date : 2023-10-20

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 3
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

>=20-<30

General Information

Version

2.0

Revision date

2023-10-20

Product name

VIRAMUNE, TABS/ 60/200MG BLI DE/AT D/A/HR

Product Synonyms

Viramune® 200 mg tablets with active ingredient: Nevirapine Anhydrous

1.2.1 Relevant identified uses

Pharmaceutical

1.2.2. Uses advised against

Safety Data Sheet only for the professional user

supplier name

Boehringer Ing. Pharma GmbH & Co. KG

Emergency telephone

+1 703-527-3887, +49800 1817059

Icons in SDS

GHS07

Company Information

company name

Boehringer Ing. Pharma GmbH & Co. KG

e-mail address of the competent person responsible for the Safety Data Sheet

EHS-Services@Boehringer-Ingelheim.com

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H302

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

OSHA Hazards GHS classification in accordance with the

2.1 Classification of the substance or mixture

in accordance with the

Signal word

Warning

Hazard statements

H302 Harmful if swallowed.

Prevention

P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.

Response

P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth.

Disposal

P501 Dispose of contents/ container to an approved waste dis- posal plant.

2.3 Other hazards

The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.